Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/balancing-antiplatelet-and-anticoagulant-therapies-in-patients-with-vrtB4bqXiv
References (50)
-
Z. Khurram, E. Chou, Robert Minutello, G. Bergman, M. Parikh, S. Naidu, S. Wong, M. Hong (2006)
Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.The Journal of invasive cardiology, 18 4
-
P. Ecurrent, E. Rial (2001)
EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION -
J. Sundström, J. Evans, E. Benjamin, D. Levy, M. Larson, D. Sawyer, D. Siwik, W. Colucci, P. Sutherland, P. Wilson, R. Vasan (2004)
Relations of Plasma Matrix Metalloproteinase-9 to Clinical Cardiovascular Risk Factors and Echocardiographic Left Ventricular Measures: The Framingham Heart StudyCirculation: Journal of the American Heart Association, 109
-
M. Lamberts, J. Olesen, M. Ruwald, C. Hansen, D. Karasoy, S. Kristensen, L. Køber, C. Torp-Pedersen, G. Gislason, M. Hansen (2012)
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort StudyCirculation, 126
-
G. Lemesle, Francesco Paparoni, C. Delhaye, L. Bonello, J. Lablanche (2011)
Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention with Drug-Eluting Stent Implantation: A Review of the Current Guidelines and LiteratureHospital Practice, 39
-
P. Karjalainen, P. Porela, A. Ylitalo, S. Vikman, K. Nyman, M. Vaittinen, Tuukka Airaksinen, M. Niemelä, T. Vahlberg, K. Airaksinen (2007)
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.European heart journal, 28 6
-
J. You, D. Singer, P. Howard, D. Lane, M. Eckman, M. Fang, E. Hylek, S. Schulman, A. Go, M. Hughes, F. Spencer, W. Manning, J. Halperin, G. Lip (2012)
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest, 141 2 Suppl
-
Shinya Goto, Masatsugu Hori, Norio Tanahashi, Michael Hanna, Suzuko Oikawa, John Alexander, Aristotle Japan (2012)
Apixaban versus Warfarin in Patients with Atrial FibrillationYearbook of Medicine, 2012
-
M. Hurlen, M. Abdelnoor, Pål Smith, J. Erikssen, H. Arnesen (2002)
Warfarin, aspirin, or both after myocardial infarction.The New England journal of medicine, 347 13
-
Deborah DeEugenio, Louis Kolman, M. DeCaro, Jocelyn Andrel, I. Chervoneva, Phu Duong, Linh Lam, C. McGowan, G. Lee, Mark Decaro, N. Ruggiero, Shalabh Singhal, A. Greenspon (2007)
Risk of Major Bleeding with Concomitant Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients Receiving Long‐Term Warfarin TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 27
-
W. Dewilde, J. Berg (2009)
Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).American heart journal, 158 5
-
R. Byrne, S. Schulz, J. Mehilli, R. Iijima, S. Massberg, F. Neumann, J. Berg, A. Schömig, A. Kastrati (2009)
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting StentAmerican heart journal, 157 4
-
C. Fang (2012)
Duration of dual antiplatelet therapy after implantation of drug-eluting stentsJournal of Cardiovascular and Pulmonary Diseases
-
D. Holmes, D. Kereiakes, N. Kleiman, D. Moliterno, G. Patti, C. Grines (2009)
Combining antiplatelet and anticoagulant therapies.Journal of the American College of Cardiology, 54 2
-
W. Dewilde, T. Oirbans, F. Verheugt, J. Kelder, B. Smet, J. Herrman, T. Adriaenssens, M. Vrolix, A. Heestermans, M. Vis, Jan Tijsen, A. Hof, J. Berg (2013)
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialThe Lancet, 381
-
J. Ruiz-Nodar, F. Marín, J. Hurtado, J. Valencia, E. Pinar, J. Pineda, J. Gimeno, F. Sogorb, M. Valdés, G. Lip (2008)
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.Journal of the American College of Cardiology, 51 8
-
F. Andreotti, L. Testa, G. Biondi-Zoccai, F. Crea (2006)
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.European heart journal, 27 5
-
S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P. Reilly, E. Themeles, Jeanne Varrone, Susan Wang, M. Alings, D. Xavier, Jun Zhu, R. Diaz, B. Lewis, H. Darius, H. Diener, C. Joyner, L. Wallentin (2009)
Dabigatran versus warfarin in patients with atrial fibrillation.The New England journal of medicine, 361 12
-
S. Wiviott, E. Braunwald, C. Mccabe, G. Montalescot, W. Rużyłło, S. Gottlieb, F. Neumann, D. Ardissino, Stefano Servi, S. Murphy, J. Riesmeyer, G. Weerakkody, M. Gibson, E. Antman (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes.The New England journal of medicine, 357 20
-
B. Gage, A. Waterman, W. Shannon, M. Boechler, M. Rich, M. Radford (2001)
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.JAMA, 285 22
-
(1994)
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.BMJ, 308 6921
-
W. Wijns (2006)
European Association of Percutaneous Cardiovascular Interventions (EAPCI).EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2 3
-
M. Rothberg, C. Celestin, L. Fiore, Elizabeth Lawler, J. Cook (2005)
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and BenefitAnnals of Internal Medicine, 143
-
M. Leon, D. Baim, J. Popma, P. Gordon, D. Cutlip, K. Ho, A. Giambartolomei, D. Diver, D. Lasorda, David Williams, S. Pocock, R. Kuntz (1999)
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.The New England journal of medicine, 339 23
-
Seung‐Jung Park, Duk‐Woo Park, Young-Hak Kim, Soo-Jin Kang, Seung‐Whan Lee, Cheol-Whan Lee, K. Han, Seong-Wook Park, S. Yun, Sang‐Gon Lee, S. Rha, I. Seong, M. Jeong, S. Hur, N. Lee, Junghan Yoon, Joo Yang, Bong-Ki Lee, Y. Choi, W. Chung, D. Lim, S. Cheong, K. Kim, J. Chae, D. Nah, D. Jeon, K. Seung, Jae-Sik Jang, H. Park, Keun Lee (2010)
Duration of dual antiplatelet therapy after implantation of drug-eluting stents.The New England journal of medicine, 362 15
-
M. Valgimigli, G. Campo, G. Percoco, M. Monti, F. Ferrari, C. Tumscitz, A. Zuffi, F. Colombo, M. Kubbajeh, Caterina Cavazza, E. Cangiano, M. Tebaldi, Monica Minarelli, Chiara Arcozzi, A. Scalone, A. Frangione, M. Borghesi, J. Marchesini, G. Parrinello, R. Ferrari (2010)
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasAmerican heart journal, 160 5
-
R. Hart, L. Pearce, M. Aguilar (2007)
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 146
-
(2012)
The WOEST trial—clinical trial results -
(Dewilde W, Oirbans T, Verheugt F, et al. The WOEST trial—clinical trial results. Paper presented at: European Society of Cardiology Congress; Aug 28, 2012; Munich, Germany.)
Dewilde W, Oirbans T, Verheugt F, et al. The WOEST trial—clinical trial results. Paper presented at: European Society of Cardiology Congress; Aug 28, 2012; Munich, Germany.Dewilde W, Oirbans T, Verheugt F, et al. The WOEST trial—clinical trial results. Paper presented at: European Society of Cardiology Congress; Aug 28, 2012; Munich, Germany., Dewilde W, Oirbans T, Verheugt F, et al. The WOEST trial—clinical trial results. Paper presented at: European Society of Cardiology Congress; Aug 28, 2012; Munich, Germany.
-
R. Es, J. Jonker, F. Verheugt, J. Deckers, D. Grobbee (2002)
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trialThe Lancet, 360
-
GY Lip, K Huber, F Andreotti (2010)
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary—a consensus document of the european society of cardiology working group on thrombosis, endorsed by the european heart rhythm association (ehra) and the european association of percutaneous cardiovascular interventions (eapci)Eur Heart J, 31
-
(2009)
Am Heart J -
([No Authors Listed.] Collaborative overview of randomised trials of antiplatelet therapy–I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet trialists’ collaboration. BMJ. 1994;308:81–106.)
[No Authors Listed.] Collaborative overview of randomised trials of antiplatelet therapy–I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet trialists’ collaboration. BMJ. 1994;308:81–106.[No Authors Listed.] Collaborative overview of randomised trials of antiplatelet therapy–I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet trialists’ collaboration. BMJ. 1994;308:81–106., [No Authors Listed.] Collaborative overview of randomised trials of antiplatelet therapy–I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet trialists’ collaboration. BMJ. 1994;308:81–106.
-
D. Lloyd‐Jones, Thomas Wang, E. Leip, M. Larson, D. Levy, R. Vasan, R. D'Agostino, J. Massaro, A. Beiser, P. Wolf, E. Benjamin (2004)
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart StudyCirculation, 110
-
J. Mega, E. Braunwald, S. Wiviott, J. Bassand, Deepak Bhatt, C. Bode, P. Burton, Marc Cohen, N. Cook-Bruns, K. Fox, S. Goto, S. Murphy, A. Plotnikov, D. Schneider, Xiang Sun, F. Verheugt, C. Gibson (2012)
Rivaroxaban in patients with a recent acute coronary syndrome.The New England journal of medicine, 366 1
-
S. Pearson, R. Troughton, A. Richards (2011)
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.The New England journal of medicine, 365 24
-
A. Go, D. Mozaffarian, V. Roger, E. Benjamin, J. Berry, W. Borden, D. Bravata, S. Dai, E. Ford, C. Fox, Sheila Franco, H. Fullerton, C. Gillespie, S. Hailpern, J. Heit, V. Howard, Mark Huffman, B. Kissela, S. Kittner, D. Lackland, J. Lichtman, L. Lisabeth, D. Magid, G. Marcus, A. Marelli, D. Matchar, Darren Mcguire, E. Mohler, C. Moy, M. Mussolino, G. Nichol, N. Paynter, P. Schreiner, P. Sorlie, J. Stein, T. Turan, S. Virani, N. Wong, D. Woo, M. Turner (2013)
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.Circulation, 127 1
-
R. Rossini, G. Musumeci, C. Lettieri, M. Molfese, Laurian Mihalcsik, P. Mantovani, V. Sirbu, T. Bass, F. Rovere, A. Gavazzi, D. Angiolillo (2008)
Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.The American journal of cardiology, 102 12
-
C. Kearon, E. Akl, A. Comerota, P. Prandoni, H. Bounameaux, S. Goldhaber, M. Nelson, P. Wells, M. Gould, F. Dentali, M. Crowther, S. Kahn (2012)
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest, 141 2 Suppl
-
R. Altman, L. Carreras, R. Diaz, E. Figueroa, E. Paolasso, J. Parodi, J. Cade, G. Donnan, M. Eadie, T. Gavaghan, E. OSullivan, D. Parkin, Renny Jtg., C. Silagy, H. Vinazzer, F. Zekert, H. Adriaensen, J. Bertrandhardy, M. Bran, J. David, J. Dricot, E. Lavennepardonge, R. Limet, A. Lowenthal, M. Moriau, S. Schapira, P. Smets, J. Symoens, R. Verhaeghe, M. Verstraete, A. Atallah, H. Barnett, R. Batista, J. Blakely, J. Cairns, R. Cote, J. Crouch, G. Evans, J. Findlay, M. Gent, Y. Langlois, J. Leclerc, J. Norris, G. Pineo, P. Powers, R. Roberts, L. Schwartz, J. Sicurella, W. Taylor, P. Théroux, A. Turpie, R. Weisel, J. Cui, L. Liu, J. Pirk, C. Bay, G. Boysen, J. Knudsen, P. Petersen, P. Sørensen, H. Tønnesen, P. Harjola, J. Arcan, B. Balkau, J. Blanchard, J. Boissel, B. Boneu, M. Bousser, M. Brochier, M. Cloarec, G. Cribier, M. Dechavanne, P. Drouin, E. Eschwège, B. Guiraudchaumeil, R. Hugonot, A. Leizorovicz, Y. Loria, L. Michat, J. Mirouze, E. Panak, J. Pasteyer, A. Rascol, L. Revol, M. Roy, J. Sellés, G. Slama, C. Starkman, M. Teule, N. Thibult, M. Verry, F. Albert, K. Andrassy, K. Breddin, R. Eckel, A. Encke, J. Frohlich, B. Hartung, H. Heiss, H. Hess, B. Hofling, D. Krause, G. Latta, H. Linke, D. Loew, R. Lorenz, K. Middleton, G. Novak, M. Oldendorf, N. Pfluger, D. Raithel, R. Reuter, G. Schettler, J. Schnitker, W. Schoop, H. Stiegler, K. Uberla, G. Vogel, M. Weber, I. Welbers, E. Zeitler, G. Arapakis, T. Chan, C. Mok, R. Szabó, N. Misra, K. Reddy, G. FitzGerald, A. Apollonio, F. Balsano, A. Basellini, L. Candelise, M. Catalano, N. Ciavarella, G. Ciuffetti, S. Coccheri, M. Cortellaro, G. Corvi, V. Coto, G. Davı̀, R. Decaterina, T. Diperri, C. Fieschi, R. Gentile, L. Gregoratti, P. Gresele, M. Lavezzari, A. Libretti, B. Magnani, Nenci Gg, G. Pagano, C. Patrono, L. Pedrini, M. Pini, P. Prandoni, F. Romeo, F. Rovelli, G. Rudelli, G. Ruvolo, G. Signorini, G. Tognoni, F. Violi, T. Fujimori, M. Kageyama, T. Katsumura, S. Kitamura, K. Maeda, A. Suzuki, H. Tohgi, S. Uchiyama, H. Utsumi, A. Garcia, A. Algra, Denottolander Gjh., Kupper Ajf., J. Vangijn, H. Hart, L. Kappelle, P. Koudstaal, T. Lemmens, J. Lodder, M. Pannebakker, P. Serruys, A. Vandenbelt, J. Vandermeer, A. Vandervijgh, Verheugt Fwa, G. Veth, J. Dale, K. Johannessen, E. Thaulow, P. Popescu, N. Tiberiu, Aznar Jrd., E. Esmatjes, P. Guiteras, J. Lasierra, P. Lopeztrigo, A. Oriol, L. Pomar, E. Rocha, F. Sanchez, J. Sanchorieger, G. Sanz, Berglund Ulf., C. Blomstrand, M. Boberg, M. Britton, C. Elwin, C. Helmers, J. Holm, L. Janzon, S. Juulmoller, H. Mulec, J. Olsson, S. Persson, G. Rasmanis, A. Rosén, K. Samuelsson, J. Soreff, N. Wahlgren, L. Wallentin, H. Baur, M. Bokslag, A. Bollinger, B. Meier, M. Pfisterer, C. Sitthiamorn, E. Acheson, P. Appleby, A. Asscher, A. Aukland, C. Baigent, S. Bala, A. Barnett, P. Bell, S. Bews, Born Gvr., J. Branagan, N. Brooks, M. Brown, N. Browse, R. Capildeo, M. Carmalt, A. Carter, I. Chalmers, M. Clarke, R. Clarke, Clyne Cac., R. Collins, Cooke, G. Coutts, D. Cove, P. Crowther, W. Cuthbertson, D. Debono, C. Dickerson, J. Dickinson, R. Doll, J. Dormandy, D. Dunbabin, S. Ell, P. Elphinstone, P. Elwood, V. Englishby, B. Farrell, C. Fiskerstrand, M. Flather, T. Foley, T. Foulds, K. Fox, P. Franks, H. Fraser, T. Gardecki, M. Gawel, A. Gent, A. Gershlick, J. Godwin, M. Goldman, C. Gray, D. Gray, R. Gray, H. Handoll, G. Hankey, Harrison Mjg., N. Henderson, S. Heptinstall, S. Hobbiger, E. Jones, Jones Nag., S. Jost, D. Julian, J. Kellett, R. Kester, G. Lowe, J. Mackenzie, C. McCollum, G. Mead, T. Meade, D. Mendelow, J. Miller, G. Morris, C. Nichol, M. Noble, Obrien, M. Ogier, S. Parish, M. Parry, R. Peto, J. Powell, P. Pozzilli, N. Qizilbash, A. Rahman, S. Rajah, D. Richards, S. Richards, R. Ripley, V. Roberts, F. Rose, Russell Rwr., P. Rubin, C. Ruckley, P. Sandercock, Shaw Mdm., K. Shaw, J. Shelley, J. Slattery, P. Sleight, S. Smith, P. Stewartlong, P. Sweetnam, Tansey Mjb., H. Tindall, J. Turney, H. Tyler, N. Varey, M. Vessey, M. Walker, M. Walker, C. Warlow, R. Wilcox, H. Willems, E. Wood, E. Wynjones, H. Adams, B. Barton, R. Bedford, B. Bick, S. Bingham, B. Brown, T. Bryant, J. Buring, C. Cabot, P. Canner, J. Chesebro, O. Chrisman, G. Clagett, J. Colwell, M. Dyken, D. Ellis, W. Fields, C. Furberg, V. Fuster, S. Goldman, J. Granett, R. Green, D. Green, R. Hardy, L. Harker, W. Harris, R. Hart, W. Hass, C. Hennekens, D. Hill, M. Hume, M. Igloe, G. Johnson, S. Jonas, G. Knatterud, T. Kohler, N. Lembo, D. Lewis, E. Lockhart, P. Majerus, Mcenany, R. McKenna, J. Mehta, J. Meyer, B. Molony, T. Moritz, D. Nicoloff, G. Nycz, H. Ono, G. Pantely, S. Phillips, P. Ridker, J. Robertson, R. Rothbart, E. Salzman, R. Sautter, R. Schlant, J. Schoenberger, M. Sengekontacket, G. Sharma, P. Steele, K. Steinnagel, J. Stratton, J. Sullivan, G. Timmis, J. Toole, Walker, S. Weisman, C. White, M. Wirecki, D. Wombolt, R. Wong, S. Yusuf, K. Zadina, D. Zucker (1994)
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 308
-
R. Nagarakanti, M. Ezekowitz, J. Oldgren, Sean Yang, M. Chernick, Timothy Aikens, G. Flaker, J. Brugada, G. Kamenský, A. Parekh, P. Reilly, S. Yusuf, S. Connolly (2010)
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing CardioversionCirculation, 123
-
N. Sarafoff, G. Ndrepepa, J. Mehilli, Katharina Dörrler, S. Schulz, R. Iijima, R. Byrne, A. Schömig, A. Kastrati (2008)
Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulationJournal of Internal Medicine, 264
-
J. Alexander, R. Lopes, S. James, R. Kilaru, Yaohua He, Puneet Mohan, Deepak Bhatt, S. Goodman, F. Verheugt, M. Flather, K. Huber, Danny Liaw, S. Husted, J. López-Sendón, R. Caterina, P. Janský, H. Darius, D. Vinereanu, J. Cornel, F. Cools, D. Atar, J. Leiva-Pons, M. Keltai, H. Ogawa, P. Pais, A. Parkhomenko, W. Rużyłło, R. Diaz, H. White, M. Ruda, M. Geraldes, J. Lawrence, R. Harrington, L. Wallentin (2011)
Apixaban with antiplatelet therapy after acute coronary syndrome.The New England journal of medicine, 365 8
-
L. Wallentin, R. Becker, A. Budaj, C. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K. Mahaffey, B. Scirica, A. Skene, P. Steg, R. Storey, R. Harrington, A. Freij, M. Thorsén (2009)
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.The New England journal of medicine, 361 11
-
S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, S. Yusuf (2006)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialThe Lancet, 367
-
G. Lip, K. Huber, F. Andreotti, H. Arnesen, J. Airaksinen, T. Cuisset, P. Kirchhof, F. Marín (2010)
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) aEuropean heart journal, 31 11
-
J. Alexander, R. Becker, Deepak Bhatt, F. Cools, F. Crea, M. Dellborg, K. Fox, S. Goodman, R. Harrington, K. Huber, S. Husted, B. Lewis, J. López-Sendón, Puneet Mohan, G. Montalescot, M. Ruda, W. Rużyłło, F. Verheugt, L. Wallentin (2009)
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) TrialCirculation, 119
-
M. Leon, D. Baim, J. Popma, P. Gordon, D. Cutlip, K. Ho, A. Giambartolomei, D. Diver, D. Lasorda, David Williams, S. Pocock, R. Kuntz (1998)
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingThe New England Journal of Medicine, 339
-
J. Mega, E. Braunwald, Satishkumar Mohanavelu, P. Burton, R. Poulter, F. Misselwitz, V. Hricák, E. Barnathan, P. Bordes, A. Witkowski, V. Markov, L. Oppenheimer, C. Gibson (2009)
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trialThe Lancet, 374
-
D. Faxon, J. Eikelboom, P. Berger, D. Holmes, Deepak Bhatt, D. Moliterno, R. Becker, D. Angiolillo (2011)
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A North American Perspective: Executive SummaryCirculation: Cardiovascular Interventions, 4
- Publisher
- Springer Journals
- Copyright
- Copyright © 2013 by The Author(s)
- Subject
- Medicine & Public Health; Internal Medicine; Cardiology
- ISSN
- 2193-8261
- eISSN
- 2193-6544
- DOI
- 10.1007/s40119-013-0015-2
- pmid
- 25135291
- Publisher site
- See Article on Publisher Site
Abstract
Anticoagulation is needed for stroke prevention in patients with atrial fibrillation. Antiplatelet therapy is essential for the prevention of stent thrombosis and the reduction of cardiovascular events in patients who undergo coronary stenting and suffer acute coronary syndromes. When these conditions overlap, the individual antithrombotic strategies are commonly combined, and the efficacy benefit of triple oral antithrombotic therapy is assumed to outweigh the bleeding risk based on the available data. Recent studies have investigated this topic further, including the first randomized controlled trial to address this issue. This new evidence challenges previous assumptions and may have implications for future practice and investigation.
Journal
Cardiology and Therapy – Springer Journals
Published: Apr 25, 2013